[Therapy for non-muscle invasive bladder cancer: HP-NAP].;La risposta immunitaria Th1 mediata nella terapia della neoplasia vescicale non muscolo invasiva: il ruolo di HP-NAP.

Urologia

Volumn 79, Issue 2, 2012, Pages 142-148

  D'Agostino, Daniele ^a   Racioppi, Marco ^b   Filianoti, Alessio ^b   Di Gianfrancesco, Luca ^b   Codolo, Gaia ^b   Fassan, Matteo ^b   Munari, Fabio ^b   Rugge, Massimo ^b   D'Elios, Mario Milco ^b   de Bernard, Marina ^b   Pagano, Francesco ^b   Bassi, Piefrancesco ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BACTERIAL PROTEIN; IMMUNOLOGICAL ADJUVANT; NEUTROPHIL ACTIVATING PROTEIN A, HELICOBACTER PYLORI; NEUTROPHIL-ACTIVATING PROTEIN A, HELICOBACTER PYLORI; TLR2 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 2; TUMOR PROTEIN;

ANIMAL; ARTICLE; BLADDER TUMOR; C57BL MOUSE; CANCER INVASION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MOTION; CHEMISTRY; DRUG EFFECT; DRUG POTENTIATION; DRUG SCREENING; HELICOBACTER PYLORI; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; INTRAVESICAL DRUG ADMINISTRATION; LYMPH NODE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TRANSITIONAL CELL CARCINOMA; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VOLUME; VASCULARIZATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRAVESICAL; ANGIOGENESIS INHIBITORS; ANIMALS; BACTERIAL PROTEINS; CARCINOMA, TRANSITIONAL CELL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; HELICOBACTER PYLORI; HUMANS; IMMUNOTHERAPY; LYMPH NODES; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; TOLL-LIKE RECEPTOR 2; TUMOR BURDEN; URINARY BLADDER NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84867918047     PISSN: 03915603     EISSN: None     Source Type: Journal    
DOI: 10.5301/RU.2012.9189     Document Type: Article

References (0)